NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to stop deadly head & neck cancer from coming back
Disease control Not yet recruitingThis study compares two different drugs given after initial cancer treatment to prevent the cancer from returning in patients with advanced nasopharyngeal carcinoma (a type of head and neck cancer). About 218 patients who have completed their main cancer treatment will receive ei…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New drug duo aims to fight back when standard treatments fail for advanced head & neck cancer
Disease control Not yet recruitingThis study is testing whether a new combination of two immunotherapy drugs, scipibaimab and tislelizumab, can help control advanced nasopharyngeal cancer that has come back or spread after standard first-line treatments have stopped working. It will involve about 37 adults whose …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Donor immune cells join fight against advanced throat cancer
Disease control Not yet recruitingThis trial is testing whether adding donor immune cells called Natural Killer (NK) cells to standard chemotherapy and radiation can reduce cancer recurrence in patients with advanced nasopharyngeal cancer. The study will first find the safest dose of these donor cells, then test …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug tested to shield cancer patients from Chemotherapy's Blood-Thinning danger
Prevention Not yet recruitingThis study is testing whether a drug called hetrombopag can prevent a serious side effect of chemotherapy for nasopharyngeal (nose and throat) cancer. The side effect, called thrombocytopenia, is when platelet counts drop too low, raising the risk of dangerous bleeding. The study…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Prevention
Last updated Apr 02, 2026 14:56 UTC
-
Scientists search for clues to make cancer immunotherapy work better
Knowledge-focused Not yet recruitingThis research study aims to understand why some patients with nasopharyngeal cancer don't respond well to immunotherapy. Researchers will analyze tumor samples from 600 patients who have already received standard cancer treatments. By studying how tumors change over time, they ho…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:35 UTC
-
New scans aim to predict cancer treatment success
Knowledge-focused Not yet recruitingThis study aims to see if two new types of PET/CT scans can help doctors more accurately stage nasopharyngeal cancer and predict how well a patient will respond to immunotherapy before they start treatment. It will involve about 732 adults with newly diagnosed cancer who have not…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC